← Back to Search

Other

Study of MR-107A-02 in the Treatment of Post Surgical Dental Pain.

Phase 2
Waitlist Available
Research Sponsored by Mylan Specialty, LP
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 hours

Summary

This trial is testing a new treatment called MR-107A-02 to see if it helps patients recover better after dental surgery.

Eligible Conditions
  • Acute Pain
  • Pain
  • Postoperative Pain

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 hours for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Overall Summed Pain Intensity Difference (SPID)
Secondary study objectives
Pain Intensity Using a Number Pain Rating Scale Utilizing 6-hour Windowed Last Observation Carried Forward (W6LOCF)
Patient's Global Assessment of Pain Control
Rescue Medication Use
+2 more

Side effects data

From 2022 Phase 2 trial • 111 Patients • NCT05317312
7%
Blood bilirubin increased
4%
Nausea
100%
80%
60%
40%
20%
0%
Study treatment Arm
MR-107A-02 1.25 mg Twice in a 24 Hour Period
MR-107A-02 5 mg Twice in a 24 Hour Period
MR-107A-02 15 mg Twice in a 24 Hour Period
Placebo Twice in a 24 Hour Period

Trial Design

4Treatment groups
Experimental Treatment
Placebo Group
Group I: MR-107A-02 5 mg twice in a 24 hour periodExperimental Treatment1 Intervention
Oral tablet, one day of dosing
Group II: MR-107A-02 15 mg twice in a 24 hour periodExperimental Treatment1 Intervention
Oral tablet, one day of dosing
Group III: MR-107A-02 1.25 mg twice in a 24 hour periodExperimental Treatment1 Intervention
Oral tablet, one day of dosing
Group IV: Placebo twice in a 24 hour periodPlacebo Group1 Intervention
Oral tablet, one day of dosing
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
MR-107A-02
2023
Completed Phase 3
~530

Find a Location

Who is running the clinical trial?

Mylan Specialty, LPLead Sponsor
3 Previous Clinical Trials
1,128 Total Patients Enrolled
2 Trials studying Acute Pain
980 Patients Enrolled for Acute Pain
~30 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top